In particular, cisplatin cytotoxicity depends on the glutathione levels and the expression of the nuclear factor erythroid 2-related factor 2 (NRF2), which controls the transcription of glutathione components in lung cancer [29] and other tumor cells [31]. This evidence concerns the gene NFE2L2 and lung carcinoma.